Showing results (251-260 of 258) with videos related to
Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 258 results.
Clinical Lung Cancer|March 22, 2021
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)Athanassios Argiris, Jieling Miao, Mihaela C Cristea, et al.Journal of Radiosurgery and SBRT|August 18, 2020
Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapyJoseph A Miccio, Andrew Barsky, Sarah Gao, et al.Journal of Neuro-Oncology|November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgeryMudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.Cancer|October 15, 2016
Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumorsVivek Verma, Valerie K Shostrom, Sameera S Kumar, et al.International Journal of Radiation Oncology, Biology, Physics|January 28, 2023
Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution ExperienceDaniel E Oliver, Jose M Laborde, Deepinder P Singh, et al.International Journal of Radiation Oncology, Biology, Physics|December 25, 2016
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung CancerVivek Verma, Charles B Simone, Pamela K Allen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017Paul Okunieff, Katherine Casey-Sawicki, Natalie A Lockney, et al.Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.Pageof 26